Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Eicosapentaenoic Acid × Clear all

Phase

Status

Completed 9 Unknown 3 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 529 Specimen Handling 436 Carboplatin 406 Magnetic Resonance Spectroscopy 391 Cisplatin 371 Cyclophosphamide 354 Radiotherapy 327 Gemcitabine 281 Bevacizumab 273 Paclitaxel 264 Biopsy 257 Drug Therapy 249 Blood Specimen Collection 227 venetoclax 210 Nivolumab 208 Capecitabine 206 Oxaliplatin 203 fludarabine 202 Docetaxel 191 Injections 184 Fluorouracil 181 Radiosurgery 165 Dexamethasone 165 Rituximab 146 Pemetrexed 145 Standard of Care 141 Surgical Procedures, Operative 138 durvalumab 131 atezolizumab 128 tislelizumab 124

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06928701 2025-04-15

NEOMET

University of Eastern Piedmont

Phase NA Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡